News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
641,500 Results
Type
Article (20862)
Company Profile (202)
Press Release (620427)
Multimedia
Podcasts (55)
Webinars (13)
Section
Business (212163)
Career Advice (707)
Deals (31993)
Drug Delivery (51)
Drug Development (65179)
Employer Resources (57)
FDA (13569)
Job Trends (11860)
News (301630)
Policy (23337)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1570)
Accelerated approval (32)
ADA (26)
Adcomms (2)
Allergies (163)
Alliances (47334)
ALS (154)
Alzheimer's disease (1336)
Antibody-drug conjugate (ADC) (422)
Approvals (14323)
Artificial intelligence (725)
ASCO (214)
Autoimmune disease (283)
Automation (61)
Bankruptcy (298)
Best Places to Work (9507)
BIO (52)
Biologics (2)
BIOSECURE Act (7)
Biosimilars (141)
BioSpace Insights (97)
Biotechnology (138)
Bladder cancer (182)
Brain cancer (52)
Breast cancer (644)
Cancer (5043)
Cardiovascular disease (345)
Career advice (639)
Career pathing (13)
CAR-T (315)
CDC (12)
Celiac Disease (1)
Cell therapy (820)
Cervical cancer (46)
Clinical research (58015)
Collaboration (2088)
Commercialization (4)
Company closure (1)
Compensation (1535)
Complete response letters (41)
COVID-19 (1532)
CRISPR (118)
C-suite (1129)
Cystic fibrosis (116)
Data (7350)
Decentralized trials (2)
Denatured (28)
Depression (124)
Dermatology (78)
Diabetes (471)
Diagnostics (6601)
Digital health (67)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (319)
Drug pricing (26)
Drug shortages (7)
Duchenne muscular dystrophy (203)
Earnings (84979)
Editorial (11)
Employer branding (9)
Employer resources (54)
Events (109179)
Executive appointments (1024)
FDA (17245)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (30)
Funding (1592)
Gene editing (244)
Generative AI (54)
Gene therapy (587)
GLP-1 (506)
Government (1888)
Grass and pollen (4)
Guidances (356)
Healthcare (14614)
Hematology (123)
HIV (71)
Huntington's disease (30)
IgA nephropathy (79)
Immunology and inflammation (141)
Immuno-oncology (75)
Indications (200)
Infectious disease (1820)
Inflammatory bowel disease (162)
Inflation Reduction Act (6)
Influenza (126)
Intellectual property (315)
Interviews (87)
IPO (15023)
IRA (10)
Job creations (2785)
Job search strategy (573)
JPM (22)
Kidney cancer (20)
Labor market (27)
Layoffs (182)
Leadership (9)
Legal (6079)
Licensing (9)
Liver cancer (76)
Longevity (30)
Lung cancer (634)
Lymphoma (350)
Machine learning (56)
Management (20)
Manufacturing (980)
Marketing (10)
MASH (149)
Medical device (13782)
Medtech (14021)
Mergers & acquisitions (18303)
Metabolic disorders (967)
mRNA (197)
Multiple sclerosis (138)
NASH (7)
Neurodegenerative disease (344)
Neuropsychiatric disorders (54)
Neuroscience (2539)
NextGen: Class of 2026 (5092)
Non-profit (2108)
Now hiring (20)
Obesity (310)
Opinion (122)
Ovarian cancer (193)
Pain (216)
Pancreatic cancer (281)
Parkinson's disease (305)
Partnered (27)
Patents (610)
Patient recruitment (712)
Peanut (61)
People (53490)
Pharmaceutical (41)
Pharmacy benefit managers (12)
Phase 1 (19148)
Phase 2 (25822)
Phase 3 (17602)
Pipeline (9617)
Policy (81)
Postmarket research (1799)
Preclinical (8276)
Press Release (69)
Prostate cancer (275)
Psychedelics (10)
Radiopharmaceuticals (320)
Rare diseases (795)
Real estate (4907)
Recruiting (25)
Regulatory (19812)
Reports (28)
Research institute (1637)
Resumes & cover letters (111)
Rett syndrome (48)
RNA editing (19)
RSV (66)
Schizophrenia (119)
Series A (282)
Series B (202)
Service/supplier (6)
Sickle cell disease (78)
Special edition (1)
Spinal muscular atrophy (106)
Sponsored (26)
Startups (3324)
State (2)
Stomach cancer (4)
Supply chain (80)
Tariffs (12)
The Weekly (25)
Vaccines (720)
Venture capital (69)
Weight loss (116)
Women's health (107)
Worklife (4)
Date
Today (62)
Last 7 days (310)
Last 30 days (2025)
Last 365 days (25350)
2026 (16586)
2025 (25432)
2024 (30334)
2023 (34967)
2022 (45426)
2021 (48929)
2020 (45896)
2019 (36612)
2018 (27484)
2017 (27452)
2016 (26454)
2015 (32975)
2014 (27969)
2013 (23918)
2012 (25883)
2011 (26238)
2010 (25138)
Location
Africa (460)
Alabama (88)
Alaska (6)
Arizona (368)
Arkansas (16)
Asia (34025)
Australia (5307)
California (13757)
Canada (3751)
China (1138)
Colorado (600)
Connecticut (537)
Delaware (320)
Europe (65099)
Florida (2068)
Georgia (446)
Hawaii (4)
Idaho (60)
Illinois (1040)
India (89)
Indiana (448)
Iowa (22)
Japan (589)
Kansas (127)
Kentucky (46)
Louisiana (42)
Maine (39)
Maryland (1528)
Massachusetts (9603)
Michigan (403)
Minnesota (755)
Mississippi (6)
Missouri (150)
Montana (31)
Nebraska (19)
Nevada (133)
New Hampshire (89)
New Jersey (3280)
New Mexico (27)
New York (3491)
North Carolina (1672)
North Dakota (10)
Northern California (6866)
Ohio (388)
Oklahoma (24)
Oregon (30)
Pennsylvania (2621)
Puerto Rico (26)
Rhode Island (50)
South America (735)
South Carolina (90)
South Dakota (1)
Southern California (5628)
Tennessee (199)
Texas (2270)
United States (47164)
Utah (426)
Vermont (2)
Virginia (241)
Washington D.C. (52)
Washington State (1106)
West Virginia (3)
Wisconsin (150)
Wyoming (2)
641,500 Results for "bluegrass vascular technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA
Leading cognitive-disorders specialist, Dr. William Shankle, will discuss vascular cognitive impairment, vascular dementia and the proposed clinical trial of VesCell™ (ACP-01) today at 12:00 EST, at https://us06web.zoom.us/webinar/register/WN_nJ8ViLkRSeiU_NXMYJ-jbw
August 20, 2026
·
12 min read
Press Releases
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
May 8, 2026
·
1 min read
Press Releases
Spectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation Technology
June 11, 2026
·
3 min read
Press Releases
Versa Vascular Appoints Bill Shields as Chief Executive Officer
August 11, 2026
·
3 min read
Press Releases
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
April 13, 2026
·
2 min read
Press Releases
Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters
June 23, 2026
·
4 min read
Press Releases
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
April 16, 2026
·
6 min read
Press Releases
CorVascular Launches ASUS Handheld Ultrasound Portfolio for Vascular Specialists at SVU 2026
July 30, 2026
·
3 min read
Press Releases
Ingenia Therapeutics Goes Public on KOSDAQ to Accelerate Pipeline of Next-Generation Vascular Antibody Therapeutics
August 18, 2026
·
5 min read
Press Releases
Vexev Raises $6M to Accelerate U.S. Commercialization of Autonomous Vascular Imaging Platform
August 6, 2026
·
3 min read
1 of 64,150
Next
